Halofuginone: Additional Phase Ib/IIa data

Data from 10 boys and young men with ambulatory or non-ambulatory DMD in the open-label, U.S. Phase Ib/IIa HALO-DMD-01/02 trial showed that once-daily HT-100 increased mean total muscle strength, as m...